tiprankstipranks

tipten - New Portfolio

Darko Markovski

tipten
Individual Investor
Ranked #498,030 out of 793,704 TipRanks' Investors
Success Rate
39%
9 out of 23
profitable transactions
Average Return
-9.48%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 6.95%
6-Month Return-
12-Month Return-
YTD Return▼ 8.49%
Total Return▼ 15.35%

Best Trade

Opened at
Closed at-
Gain▲ 61.68%

Bio

Performance

26.01%0-26.01%
▼ 13.14%
▲ 2.34%
Aug 2024
▲ 2.93%
▲ 2.10%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 3.10%
Oct 2024
▲ 26.01%
▲ 5.96%
▲ 2.89%
Nov 2024
▲ 5.34%
▼ 2.41%
▼ 7.22%
Dec 2024
▲ 5.88%
▲ 2.69%
▲ 0.55%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 2.19%
Feb 2025
▲ 5.30%
▼ 4.02%
▼ 6.95%
Mar 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 13.14%▲ 2.34%
▲ 2.93%▲ 2.10%
▲ 10.00%▼ 0.89%▼ 3.10%
▲ 26.01%▲ 5.96%▲ 2.89%
▲ 5.34%▼ 2.41%▼ 7.22%
▲ 5.88%▲ 2.69%▲ 0.55%
▼ 12.86%▼ 1.27%▼ 2.19%
▲ 5.30%▼ 4.02%▼ 6.95%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Ish.Frf Sp Tech
▼ 0.82%
2
Close
Nov 27, 2024
Vang S&P 500 Ptg.Shs Exchange Traded Fund USD
▲ 3.07%
2
Close
Nov 27, 2024
VanEck Semiconductor UCITS ETF Accum A USD
▼ 7.13%
2
Close
Nov 27, 2024
Regis
4.97%
▼ 22.54%
1
Open
Nov 27, 2024
Ceribell, Inc.
3.81%
▼ 31.24%
1
Open
Nov 27, 2024
Universal Technical Institute
5.67%
▲ 1.77%
1
Open
Nov 27, 2024
Illumina
3.16%
▼ 43.00%
1
Open
Nov 27, 2024
Centrus Energy
4.55%
▼ 16.23%
1
Open
Nov 27, 2024
Bill.com Holdings
2.92%
▼ 46.02%
1
Open
Nov 27, 2024
NRG Energy
5.78%
▼ 2.75%
1
Open
Nov 27, 2024
ON Semiconductor
3.36%
▼ 37.80%
1
Open
Nov 27, 2024
Adtran
5.82%
▲ 9.89%
1
Open
Nov 27, 2024
Crocs
5.46%
▲ 4.73%
1
Open
Nov 27, 2024
Fortinet
6.01%
▲ 5.83%
1
Open
Nov 27, 2024
Verona Pharma
8.85%
▲ 61.68%
1
Open
Nov 27, 2024
Inhibikase Therapeutics
5.55%
▼ 13.19%
1
Open
Nov 27, 2024
Core Scientific Inc
2.38%
▼ 55.51%
1
Open
Nov 27, 2024
PureCycle Technologies
3.12%
▼ 44.09%
1
Open
Nov 27, 2024
Aldeyra Therapeutics
6.9%
▲ 26.72%
1
Open
Nov 27, 2024
Mama's Creations
3.89%
▼ 30.97%
1
Open
Nov 27, 2024